BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 11551109)

  • 1. Universal newborn screening for Hb H disease in California.
    Lorey F; Cunningham G; Vichinsky EP; Lubin BH; Witkowska HE; Matsunaga A; Azimi M; Sherwin J; Eastman J; Farina F; Waye JS; Chui DH
    Genet Test; 2001; 5(2):93-100. PubMed ID: 11551109
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection of alpha-thalassemia in beta-thalassemia carriers and prevention of Hb Bart's hydrops fetalis through prenatal screening.
    Li D; Liao C; Li J; Xie X; Huang Y; Zhong H
    Haematologica; 2006 May; 91(5):649-51. PubMed ID: 16627247
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Newborn screening for Hb H disease by determination of Hb Bart's using the Sebia capillary electrophoresis system in southern China.
    Liao C; Zhou JY; Xie XM; Tang HS; Li R; Li DZ
    Hemoglobin; 2014; 38(1):73-5. PubMed ID: 24229410
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of Deletional Hb H Diseases in Samples with Hb A
    Khongthai K; Ruengdit C; Panyasai S; Pornprasert S
    Hemoglobin; 2019; 43(4-5):245-248. PubMed ID: 31687860
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Simplified PGD of common determinants of haemoglobin Bart's hydrops fetalis syndrome using multiplex-microsatellite PCR.
    Wang W; Yap CH; Loh SF; Tan AS; Lim MN; Prasath EB; Chan ML; Tan WC; Jiang B; Yeo GH; Mathew J; Ho A; Ho SS; Wong PC; Choolani MA; Chong SS
    Reprod Biomed Online; 2010 Nov; 21(5):642-8. PubMed ID: 20864413
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Screening for common nondeletional α-thalassemias in Chinese newborns by determination of Hb Bart's using the Sebia Capillarys 2 electrophoresis system.
    Tang HS; Zhou JY; Xie XM; Li R; Liao C; Li DZ
    Hemoglobin; 2012; 36(2):196-9. PubMed ID: 22239481
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of Hb Bart's Hydrops Fetalis Caused by - -
    He S; Li J; Huang P; Zhang S; Lin L; Zuo Y; Tian X; Zheng C; Qiu X; Chen B
    Hemoglobin; 2018 Jan; 42(1):61-64. PubMed ID: 29493331
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neonatal screening for alpha-thalassemia in southern Taiwan.
    Lin TM; Eng HL; Kuo PL; Wu HL
    J Formos Med Assoc; 1992 Dec; 91(12):1213-5. PubMed ID: 1363647
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rapid and accurate quantitation of Hb Bart's and Hb H using weak cation exchange high performance liquid chromatography: correlation with the alpha-thalassemia genotype.
    Papassotiriou I; Traeger-Synodinos J; Vlachou C; Karagiorga M; Metaxotou A; Kanavakis E; Stamoulakatou A
    Hemoglobin; 1999 Aug; 23(3):203-11. PubMed ID: 10490132
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnostic applications of newborn screening for α-thalassaemias, haemoglobins E and H disorders using isoelectric focusing on dry blood spots.
    Jindatanmanusan P; Riolueang S; Glomglao W; Sukontharangsri Y; Chamnanvanakij S; Torcharus K; Viprakasit V
    Ann Clin Biochem; 2014 Mar; 51(Pt 2):237-47. PubMed ID: 23901141
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Accurate prenatal diagnosis of Hb Bart's hydrops fetalis in daily practice with a double-check PCR system.
    Karnpean R; Fucharoen G; Fucharoen S; Sae-ung N; Sanchaisuriya K; Ratanasiri T
    Acta Haematol; 2009; 121(4):227-33. PubMed ID: 19546525
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prenatal diagnosis of Hb Bart's hydrops fetalis caused by a genetic compound heterozygosity for two different alpha-thalassemia determinants.
    Siriratmanawong N; Pinmuang-Ngam C; Fucharoen G; Fucharoen S
    Fetal Diagn Ther; 2007; 22(4):264-8. PubMed ID: 17369692
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic value of fetal hemoglobin Bart's for evaluation of fetal α-thalassemia syndromes: application to prenatal characterization of fetal anemia caused by undiagnosed α-hemoglobinopathy.
    Singha K; Yamsri S; Chaibunruang A; Srivorakun H; Sanchaisuriya K; Fucharoen G; Fucharoen S
    Orphanet J Rare Dis; 2022 Feb; 17(1):45. PubMed ID: 35144630
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neonatal screening for α-thalassemia by cord hemoglobin Barts: how effective is it?
    Wu MY; Xie XM; Li J; Li DZ
    Int J Lab Hematol; 2015 Oct; 37(5):649-53. PubMed ID: 25955662
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cord blood screening for alpha-thalassemia and hemoglobin variants by isoelectric focusing in northern Thai neonates: correlation with genotypes and hematologic parameters.
    Charoenkwan P; Taweephol R; Sirichotiyakul S; Tantiprabha W; Sae-Tung R; Suanta S; Sakdasirisathaporn P; Sanguansermsri T
    Blood Cells Mol Dis; 2010 Jun; 45(1):53-7. PubMed ID: 20299254
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prenatal diagnosis of hemoglobin Bart's hydrops fetalis by HPLC analysis of hemoglobin in fetal blood samples.
    Sanguansermsri T; Thanaratanakorn P; Steger HF; Tongsong T; Sirivatanapa P; Wanapirak C; Sirichotiyakul S; Chanprapas P; Flatz G
    Southeast Asian J Trop Med Public Health; 2001 Mar; 32(1):180-5. PubMed ID: 11485083
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alpha-thalassemia: Hb H disease and Hb Barts hydrops fetalis.
    Chui DH
    Ann N Y Acad Sci; 2005; 1054():25-32. PubMed ID: 16339648
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic origin of α
    Jomoui W; Fucharoen G; Sanchaisuriya K; Charoenwijitkul P; Maneesarn J; Xu X; Fucharoen S
    J Hum Genet; 2017 Aug; 62(8):747-754. PubMed ID: 28381876
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Electrophoresis features and genotypes of Hb bart's hydrops fetalis.
    Li Y; Liang L; Tian M; Qing T; Wu X
    Scand J Clin Lab Invest; 2020; 80(2):129-132. PubMed ID: 31841045
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early onset of fetal hydrops associated with the α-thalassemia - -(THAI) deletion.
    Yang Y; Li DZ
    Hemoglobin; 2014; 38(6):431-4. PubMed ID: 25370866
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.